Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Koning

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Journal of Biomedical Nanotechnology|June 16, 2016
A Novel Combined Approach of Short-Chain Sphingolipids and Thermosensitive Liposomes for Improved Drug Delivery to Tumor CellsAzadeh Haeri, Lilia R C Pedrosa, Timo L M Ten Hagen, et al.
The Journal of Biological Chemistry|May 22, 2002
Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteinsEnrico Mastrobattista, Gerben A Koning, Louis van Bloois, et al.
Molecular Imaging|March 16, 2012
Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imagingStefan E Pool, Timo L M ten Hagen, Stuart Koelewijn, et al.
Nutricion Hospitalaria|June 11, 1999
[Critical analysis of the evolution of commercial preparations for enteral nutrition during 1988-1996]N Hillman, D del Olmo, A Koning, et al.
The Journal of Infectious Diseases|September 10, 2003
Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infectionFransje A Koning, David Kwa, Brigitte Boeser-Nunnink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infectionFransje A Koning, Sigrid A Otto, Mette D Hazenberg, et al.
Bioorganic & Medicinal Chemistry|July 14, 2010
Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronateKristina Djanashvili, Timo L M ten Hagen, Roy Blangé, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2015
Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor regionMohamadreza Amin, Mercedeh Mansourian, Gerben A Koning, et al.
Nutricion Hospitalaria|October 26, 2001
[Concordance between body self-perception and BMI estimated in a population of volunteers recruited on the IV National Day of Obese People]B Cánovas, M Ruperto, E Mendoza, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 10, 2013
Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imagingAnn L B Seynhaeve, Bilyana M Dicheva, Saske Hoving, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Journal of Biomedical Nanotechnology|June 16, 2016
A Novel Combined Approach of Short-Chain Sphingolipids and Thermosensitive Liposomes for Improved Drug Delivery to Tumor CellsAzadeh Haeri, Lilia R C Pedrosa, Timo L M Ten Hagen, et al.
The Journal of Biological Chemistry|May 22, 2002
Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteinsEnrico Mastrobattista, Gerben A Koning, Louis van Bloois, et al.
Molecular Imaging|March 16, 2012
Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imagingStefan E Pool, Timo L M ten Hagen, Stuart Koelewijn, et al.
Nutricion Hospitalaria|June 11, 1999
[Critical analysis of the evolution of commercial preparations for enteral nutrition during 1988-1996]N Hillman, D del Olmo, A Koning, et al.
The Journal of Infectious Diseases|September 10, 2003
Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infectionFransje A Koning, David Kwa, Brigitte Boeser-Nunnink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infectionFransje A Koning, Sigrid A Otto, Mette D Hazenberg, et al.
Bioorganic & Medicinal Chemistry|July 14, 2010
Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronateKristina Djanashvili, Timo L M ten Hagen, Roy Blangé, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2015
Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor regionMohamadreza Amin, Mercedeh Mansourian, Gerben A Koning, et al.
Nutricion Hospitalaria|October 26, 2001
[Concordance between body self-perception and BMI estimated in a population of volunteers recruited on the IV National Day of Obese People]B Cánovas, M Ruperto, E Mendoza, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 10, 2013
Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imagingAnn L B Seynhaeve, Bilyana M Dicheva, Saske Hoving, et al.
Pageof 14